Table 1 Episcreen assay
Sample | Mean SI* | SD | % Response |
|---|---|---|---|
IgETRAP | 2.78 | ± 0.63 | 9 |
Omalizumab (Xolair) | 2.12 | ± 0.06 | 4 |
Trastzumab (Herceptin) | 2.72 | ± 0.45 | 9 |
Exenatide (Bydureon) | 2.99 | ± 1.62 | 43 |
Keyhole limpet hemocyanin (KLH) | 11.78 | ± 9.26 | 96 |
Sample | Mean SI* | SD | % Response |
|---|---|---|---|
IgETRAP | 2.78 | ± 0.63 | 9 |
Omalizumab (Xolair) | 2.12 | ± 0.06 | 4 |
Trastzumab (Herceptin) | 2.72 | ± 0.45 | 9 |
Exenatide (Bydureon) | 2.99 | ± 1.62 | 43 |
Keyhole limpet hemocyanin (KLH) | 11.78 | ± 9.26 | 96 |